12d
Dezeen on MSNFinger-waggling exoskeleton helps pianists play fasterJapanese researchers have used a nimble robotic hand exoskeleton to train expert pianists to improve their performance, using ...
In a report released yesterday, David Stanton from Jefferies maintained a Buy rating on CSL (CMXHF – Research Report), with a price target of A$333.00. The company’s shares closed yesterday at ...
CSL (CSLLY) and Arcturus Therapeutics (ARCT) announced that the European Commission has granted marketing authorization for Kostaive, a self-amplifying mRNA COVID-19 vaccine, for individuals 18 ...
Australian biopharmaceutical company CSL posted higher first-half profits as growth in its main blood-plasma business helped offset weaker flu vaccine sales, which were hit by "significantly" low ...
Learn More CSL Ltd (ASX: CSL) shares couldn't avoid the broader market sell-off on Monday. Shares in the S&P/ASX 200 Index (ASX: XJO) biotech stock ended the day down 1.4%, trading for $276.42 apiece.
DAYTONA BEACH, Fla. (CHARLOTTE SPORTS LIVE) — There’s a reason they call it the Granddaddy of Racing. From Gordon to Earnhardt, Daytona has seen all the greats and through the track’s racing ...
Learn More If you have been thinking about buying CSL Ltd (ASX: CSL) shares, then read on. That's because Goldman Sachs has just named another reason to buy the biotechnology giant's shares.
OpenAI’s big rebranding effort brings a new logo and a new typeface, OpenAI sans. OpenAI’s big rebranding effort brings a new logo and a new typeface, OpenAI sans. Emma Roth is a news writer ...
Ahead of tomorrow’s Champions League meeting with Girona in Spain, see how the team have been preparing in training It’s the final matchday of the league phase, and while a top eight-finish is not ...
With a free weekend and midweek, our players headed off to Dubai on Thursday to embark on some warm-weather training, and you can see what's been going on out in the UAE with a special edition of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results